BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10695025)

  • 1. [Antimicrobial activities of meropenem against clinically isolated strains in 1997].
    Suzuki Y; Matsumoto Y; Nishinari C; Endo H; Ishihara R; Deguchi K
    Jpn J Antibiot; 1999 Dec; 52(12):695-720. PubMed ID: 10695025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial activities of meropenem against clinically isolated strains].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Feb; 49(2):175-93. PubMed ID: 8721078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
    Kinoshita S; Kumagai S
    Jpn J Antibiot; 1998 Sep; 51(9):551-60. PubMed ID: 9846282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
    Abe T; Fukuoka T; Sato Y; Ito K; Sei M
    Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
    Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
    Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activity of biapenem against recent clinical isolates].
    Hara T; Araake M; Watabe H
    Jpn J Antibiot; 2003 Apr; 56(2):138-41. PubMed ID: 12825414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
    Suzuki Y; Nishinari C; Endo H; Tamura C; Jinbo K
    Jpn J Antibiot; 2001 Sep; 54(9):473-90. PubMed ID: 11729712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparison of susceptibility of Pseudomonas aeruginosa clinical isolates to carbapenem antibiotics in our hospital].
    Kakeya H; Yamada K; Nakaie K; Takizawa E; Okada Y; Fujita A; Nakamura Y; Abe J; Hirose A; Kaneko Y; Hino M
    Jpn J Antibiot; 2014 Aug; 67(4):241-8. PubMed ID: 25420320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
    Ito K; Hashimoto K; Ogata H
    Kekkaku; 2003 Sep; 78(9):587-90. PubMed ID: 14577345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial activities of meropenem against clinically isolated strains in 1999].
    Suzuki Y; Nishinari C; Endo H; Tamura C
    Jpn J Antibiot; 2001 Apr; 54(4):145-70. PubMed ID: 11436501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents].
    Igari J; Watanabe N; Uehara N; Inoue M; Yoshida H; Imafuku Y; Nishino T; Shibano T; Satou S; Kobayashi I; Takahashi A; Yomoda S; Matsuoka K; Oguri T; Ohba Y; Kumasaka K; Tokuda K; Kobayashi Y; Hongo T; Okada J; Sasaki T; Matsumoto N; Hirata Y; Nakasaki N; Ono J; Takata T; Kawaguchi R; Ohtaki Y; Kajimura K; Ishigo S; Hashimoto T; Aoki N; Okamoto E; Murakami E; Saeki H
    Jpn J Antibiot; 2000 Mar; 53(3):157-70. PubMed ID: 10834147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
    Arita K; Daido K; Ohashi N; Nakamura K; Takeshima Y; Kohara T
    Jpn J Antibiot; 1999 Jul; 52(7):491-6. PubMed ID: 10516928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In-vitro activity of panipenem against clinical isolates in 2006].
    Yoshida S; Koga T; Kakuta M; Kobayashi I; Matsuzaki K; Urabe E; Omika K; Hasegawa M; Sato Y
    Jpn J Antibiot; 2008 Feb; 61(1):1-17. PubMed ID: 18536215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2002].
    Yamaguchi K; Ishii Y; Iwata M; Yoshida H; Satoh T; Watanabe N; Uehara N; Murakami M; Takahashi A; Yasujima M; Kasai T; Itoh K; Shibuya Y; Suwabe A; Obata R; Kanno H; Kubo S; Kaku M; Kanemitsu K; Maesaki S; Hashikita G; Igari J; Oguri T; Aihara M; Kinoshita S; Okada J; Tazawa Y; Taminato T; Negayama K; Nakashima H; Takemura H; Murase M; Miyamoto H; Horii T; Kusano N; Mihara E; Baba H; Ishigo S; Kambe M; Itaha H; Fujita N; Komori T; Ono J; Yoshimura H; Ichiyama S; Maeda S; Hirakata Y; Matsuda J; Yamanaka K; Murata Y; Saikawa T; Hiramatsu K
    Jpn J Antibiot; 2004 Feb; 57(1):70-104. PubMed ID: 15116574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2004].
    Yamaguchi K; Murakami M; Takahashi A; Ishii Y; Iwata M; Itoh K; Oohara T; Watanabe N; Uehara N; Nomura F; Watanabe M; Yasujima M; Kasai T; Kanno H; Aihara M; Suwabe A; Yamahata K; Maesaki S; Hashikita G; Kaku M; Kanemitsu K; Miyake K; Oguri T; Yoshida H; Nishiyama K; Okada J; Tazawa Y; Komatsu M; Nakashima H; Takemura H; Kinoshita S; Okada M; Kobayashi S; Taminato T; Negayama K; Horii T; Murase M; Miyamoto H; Baba H; Kusano N; Mihara E; Ishigo S; Kambe M; Itaha H; Fujita N; Komori T; Ono J; Yoshimura H; Ichiyama S; Maeda S; Hirakata Y; Matsuda J; Yamanaka K; Mutara Y; Saikawa T; Hiramatsu K; Taminato S
    Jpn J Antibiot; 2005 Dec; 58(6):655-89. PubMed ID: 16521347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
    Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Nukiwa T; Shoji S; Honda Y
    Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bactericidal activity of biapenem against various bacteria].
    Hiraishi T; Miyata A; Hara T; Araake M; Ogawa H
    Jpn J Antibiot; 2001 Dec; 54(12):581-95. PubMed ID: 11877858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of antibiotics by the method of initial bactericidal activity].
    Matsuda K; Inoue M
    Jpn J Antibiot; 2000 Dec; 53(12):667-71. PubMed ID: 11234223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid bactericidal activities of carbapenems against Pseudomonas aeruginosa in simulating human plasma concentrations].
    Ishii C; Kakuta M; Abe T; Fukuoka T; Inoue M
    Jpn J Antibiot; 2002 Apr; 55(2):187-95. PubMed ID: 12071096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.